Showing 5241-5250 of 5771 results for "".
- Johnson & Johnson Vision’s Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Resultshttps://modernod.com/news/johnson-johnson-visions-investigational-antihistamine-releasing-contact-lens-demonstrates-positive-phase-3-results/2476418/Johnson & Johnson Vision announced that results from two phase 3 clinical studies evaluating the company’s investigational antihistamine-releasing contact lens (etafilcon A with 0.019 mg ketotifen) were published in the journal Cornea. The results demonstrated that patients weari
- Quantel Medical Receives FDA Approval for ABSolu Ultrasound Platformhttps://modernod.com/news/quantel-medical-receives-fda-approval-for-absolu-ultrasound-platform/2476415/Quantel Medical announced that it has received approval from the FDA for the new A/B/S ultrasound platform: ABSolu. The ABSolu includes a new 5 ring annular technology 20MHz B probe that increases the depth of
- Eyepromise Introduces Screen Shield Teen All-Natural Eye Vitamin for Screen Time Protectionhttps://modernod.com/news/eyepromise-introduces-screen-shield-teen-all-natural-eye-vitamin-for-screen-time-protection/2476410/EyePromise announced the introduction of Screen Shield Teen to its premium EyePromise eye vitamin line. Screen Shield Teen is an ocular nutrition supplement specially formulated to preserve and support visual comfort and wellness for children ages 4-17. The vast majority of teens in the Un
- Study Examines Using Re-Esterified Omega-3 and Maqui Berry in Combination as a Treatment for Dry Eye Diseasehttps://modernod.com/news/study-examines-using-re-esterified-omega-3-and-maqui-berry-in-combination-as-a-treatment-for-dry-eye-disease/2476402/Focus Laboratories has announced that a clinical study on their VitaSight O3+Maqui Dietary Supplement, conducted by Edward Paul, PhD, was published in the Journal of Clinical & Experiment
- Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japanhttps://modernod.com/news/aerie-pharmaceuticals-initiates-netarsudil-ophthalmic-solution-phase-2-clinical-trial-in-japan/2476406/Aerie Pharmaceuticals announced the commencement of patient dosing in its phase 2 clinical trial designed in accordance with the requirements of Japan’s PMDA (Pharmaceuticals and Medical Devices Agency) to support potential regulatory submission of netarsudil ophthalmic solution in Japan. Netarsu
- Aerie Pharmaceuticals Initiates Phase 2 Clinical Trial of AR-1105 in Patients with Macular Edema Associated with RVOhttps://modernod.com/news/aerie-pharmaceuticals-initiates-phase-2-clinical-trial-of-ar-1105-in-patients-with-macular-edema-associated-with-rvo/2476401/Aerie Pharmaceuticals announced the commencement of patient dosing in a phase 2 clinical trial of AR-1105, its investigational dexamethasone intravitreal implant, in patients with macular edema due to retinal vein occlusion (RVO). This phase 2 study (AR1105-CS201) will be conducted at appr
- VSP Global Names Steve Baker President of VSP Ventureshttps://modernod.com/news/vsp-global-names-steve-baker-president-of-vsp-ventures/2476398/VSP Global has announced the appointment of Steve Baker, president of Eyefinity, to lead the newly-established VSP Ventures, according to a report in VisionMonday. “Steve’
- Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kithttps://modernod.com/news/q-biomed-and-mannin-research-to-develop-gdf15-biomarker-glaucoma-diagnostic-kit/2476396/Q BioMed announced that its technology partner Mannin Research has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression. This enabling te
- SynergEyes Launches Tangible Hydra-PEG Coating on SynergEyes VS Scleral Lenshttps://modernod.com/news/synergeyes-launches-tangible-hydra-peg-coating-on-synergeyes-vs-scleral-lens/2476394/SynergEyes announced that the SynergEyes VS scleral lens is now available with Tangible Hydra-PEG on Contamac material. The Tangible Hydra-PEG coating is designed to solve the problem of contact lens discomfort and dry eyes by minimizing deposits and lens fogging, increasing lens surface water re
- Lilliana Vazquez to Moderate Vision Expo’s EYE2EYE Series with Commonhttps://modernod.com/news/lilliana-vazquez-to-moderate-vision-expos-eye2eye-series-with-common/2476392/Vision Expo has announced Lilliana Vazquez will moderate its inaugural EYE2EYE series with award-winning artist Common. Ms. Vazquez is a multi-media personality that has acted as a host, influencer, style advisor and producer for the biggest names in entertainment, including working as a contribu